ISG to Evaluate AI Services in Healthcare

Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, has launched a research study examining providers that help healthcare enterprises move from early experimentation to real-world adoption of AI.

The study results will be published in a comprehensive ISG Provider Lens report, called AI Services in Healthcare, scheduled to be released in April 2026. The report will cover companies offering AI strategy, advisory, development and delivery services to healthcare enterprises.

Enterprise buyers will be able to use information from the report to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information to recommend providers to the firm’s buy-side clients.

Healthcare organizations are rapidly adopting AI to tackle the growing burden of clinical work, address operational pressures and improve patient experience. The gradual uptake of generative AI (GenAI) and agentic AI models, alongside traditional AI, has helped enterprises automate routine tasks and enhance reasoning and orchestration in clinical and operational workflows. Organizations are applying AI in growth areas such as clinical decision support, imaging, virtual care, revenue cycle tasks and population health analysis, supported by tools that are increasingly tailored to healthcare needs. Cloud-based AI platforms and emerging interoperability standards are also strengthening enterprises’ ability to implement AI in a secure and scalable manner.

“Enterprises across the health sector are facing significant challenges, such as data fragmentation and privacy and regulatory constraints,” said Iain Fisher, director at ISG. “As they continue to adopt agentic AI, the need for strong guardrails, oversight and safety management becomes even more critical.”

ISG has distributed surveys to approximately 100 providers. Working in collaboration with ISG’s global advisors, the research team will produce two quadrants representing AI-related services the typical healthcare enterprise is buying, based on ISG’s experience working with its clients. The two quadrants are:

• Healthcare AI Strategy and Advisory Services, evaluating providers that guide organizations in planning and governing AI, GenAI and agentic AI adoption. They offer expertise in selecting and validating healthcare-specific large language models (LLMs), ensuring alignment with clinical, operational and financial goals.
• Healthcare AI Development and Delivery Services, assessing providers that design, build, deploy and operationalize AI solutions for payers and healthcare firms. These providers are further evaluated on their expertise in model development and their ability to integrate these solutions with electronic health records (EHRs), care management platforms and other core systems.

The report produced from the study will cover the global market for AI services in healthcare and examine offerings available worldwide. ISG analysts Rohan Sinha and Sneha Jayanth will serve as authors of the report.